AzTrials
AzTrials

Physical Activitym-LIfENCT06981247

Cardiovascular Disease Prevention Strategies for High-risk Urban Sedentary Employees in Karachi, Pakistan

A study testing m-LIfE: mobile based lifestyle intervention for employees to increase their physical activity and promote healthy diet. and Routine care arm in people with Physical Activity and Life Style, run by Aga Khan University at 1 site in Pakistan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Heart diseases and other non-communicable diseases are serious health issues in countries like Pakistan. Many people who work in offices, like bank employees, sit for more than 8 hours a day. This is called a sedentary lifestyle, and it increases the risk of heart diseases. Read more about this study

Who is it for?
Ages 20 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Physical Activity, Life Style, Dietary Habits
What is being tested?
m-LIfE: mobile based lifestyle intervention for employees to increase their physical activity and promote healthy diet. and Routine care arm
Could I receive a placebo?
No, everyone receives an active treatment
How many people
84 participants
Where
1 sitePakistan
Study dates
22 Jun 2026to Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • At least 6 months of job experience in any bank

Who cannot join

  • Diagnosed case of myocardial infarction, stroke, coronary heart disease, cerebrovascular disease, or peripheral arterial diseases
  • Pregnant women
  • Individuals with acute illnesses that limit physical activity

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Pakistan1 site, 1 recruiting
  • Aga Khan University

    Karachi, Sindh, 74800

    Samina Akhtar, 00923314312920, samina.yousanaf@aku.edu

    Recruiting

Other trials in Pakistan

About this study

Official title: m-Lifestyle Intervention for Employees (m-LIfE): Protocol for a Pilot Cluster Randomized Controlled Trial on Cardiovascular Disease Prevention Strategies

Heart diseases and other non-communicable diseases are serious health issues in countries like Pakistan. Many people who work in offices, like bank employees, sit for more than 8 hours a day. This is called a sedentary lifestyle, and it increases the risk of heart diseases.

This research project aims to find out if a newly developed context specific mobile phone application can help these sedentary employees to improve their lifestyle. The app, called m-LIfE (mHealth-based Lifestyle Intervention for Employees), will be designed to help employees to move more during the day and eat healthier food like fruits and vegetables.

Read more

The study will involve bank employees in urban Karachi, Pakistan. They will be divided into two arms:

Intervention arm: Participants in this arm will use the m-LIfE app for 12 weeks. They will get reminders and tips to take breaks, exercise, and eat healthy.

Routine care arm: Participants in this arm will receive printed basic educational material about prevention of risk factors of heart diseases and improving lifestyle.

After the 12 weeks of intervention, there will be a follow-up period at 4th week to check if participants are maintaining healthy habits.

This study could help find simple and affordable ways to improve the health of office workers and reduce pressure on the healthcare system.

Read the detailed description

Cardiovascular diseases (CVD) are the leading cause of mortality globally, with developing countries bearing a disproportionate burden of associated risk factors. Alarmingly, the age of onset of CVD is decreasing in these settings. Despite the significant burden, preventive strategies targeting modifiable risk factors often receive insufficient attention. Pakistan, as the fifth most populous country in the world and a low and middle-income country (LMIC) with a fragile healthcare system, relies heavily on out-of-pocket payments for healthcare (73% of the population). In this context, addressing CVD risk factors at the population level and targeting high-risk populations becomes an essential strategy for combating CVD.

The banking sector in particular has been facing a tremendous change for several years due to the increasing number of new entrants, which has increased competition among the banks. Economic uncertainties and political instability have also affected the industry and consequently the health outcomes of its employees who are considered high risk urban sedentary workers as they spend more than 8 hours of their daytime sitting with minimal physical activity (PA) and consuming high lipid diet. This behavior predisposes them to CVD unless they take preventive health behaviors (engage in regular PA, increase fruit and vegetable intake, and reduce fatty meals, sugar, and salt intake). Lifestyle modification aimed at improving PA and dietary habits is the first-line approach to reducing cardiovascular risk. However, the feasibility of implementing such strategies in urban environments needs to be examined. Currently, little is known about which intervention components would be most effective in improving the lifestyle behaviors of bank employees.

Pertinently, the workspaces of most bank branches in Pakistan lack suitable areas for relaxation or PA, further exacerbating the sedentary nature of their work. Consequently, this high-risk group requires targeted efforts to increase their knowledge and address their lifestyle behaviors for effective CVD prevention. Therefore, the development and testing of strategies specifically tailored to this occupational group are of utmost importance.

The overall aim of this research project is to develop and assess the feasibility of m-LIfE (mHealth-based Lifestyle Intervention for Employees) to improve lifestyle in high-risk urban sedentary employees (bank employees) from Karachi, Pakistan. The specific objectives are (1) To explore awareness (perception and preferences) about CVD and its prevention among high-risk sedentary employees, and design m-LIfE (2) To assess feasibility of m-LIfE versus routine care among high-risk sedentary employees. The secondary objective is to report potential efficacy on lifestyle (PA and dietary intake) in both m-LIfE and routine arm.

This study will employ a mixed-methods approach, beginning with an exploratory qualitative phase and followed by a pilot cluster randomized controlled trial (cRCT). The qualitative component will explore awareness, perceptions, and preferences regarding CVD and its prevention. Following this, m-LIfE app will be developed using human centered design approach.

The pilot cRCT will evaluate the feasibility and potential efficacy of the m-LIfE over a 12-week intervention period, with a 4-week follow-up. Ten clusters (bank branches) will be randomly selected out of 313 branches across Karachi, out of which five will be randomized to the m-LIfE intervention, and five clusters will serve as the routine care arm. The study will be conducted in branches of two commercial private banks located in urban Karachi, Pakistan.

Being tested
m-LIfE: mobile based lifestyle intervention for employees to increase their physical activity and promote healthy diet., Routine care arm
Keywords
Primary care, Cardiology, Preventive medicine, risk perception, cardiovascular health, CVD, Sedentary lifestyle, mHealth, Digital health, Feasibility
Medical subject headings
Motor Activity, Feeding Behavior, Cardiovascular Diseases, Sedentary Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • m-LIfE: mobile based lifestyle intervention for employees to increase their physical activity and promote healthy diet.Behavioural

    The m-LIfE will primarily deliver healthy lifestyle educational content, provide customized strategies for PA, and offer participants the option to enter their daily intake of fruits and vegetables through Food Log feature. m-LIfE will track PA and diet, send tailored reminders, and provide motivational messages. Participants will receive two text messages daily: a goal reminder in the morning and feedback or reflection on their progress in the evening. Additionally, they will receive one motivational message at the end of each week to sustain their motivation. Personalized feedback will also be provided through the application, featuring graphs to illustrate daily, weekly, and monthly progress.

    To support participants further, the application will enable two-way communication, allowing users to seek assistance and ask questions from the research team. A dedicated contact number will be made available within the app to facilitate direct communication.

  • Routine care armOther

    Participants in the routine care arm will receive educational material in the form of paper-based pamphlets to ensure they still benefit from basic health information on CVD risk prevention. They will continue their usual work routines without access to the app, but their PA and dietary habits will be assessed at baseline, post-intervention and at follow-up for comparative purposes.

Study groups in NCT06981247
Study groupRoleWhat they receive
m-LIfEExperimentalParticipants in the intervention arm will receive mHealth application (m-LIfE). The application will be installed on participants' personal mobile phones, and each participant will be provided with a unique user ID and password.
Receives: Behavioral: m-LIfE: mobile based lifestyle intervention for employees to increase their physical activity and promote healthy diet.
Routine care armOtherParticipants in the routine care arm will receive basic educational material in the form of paper-based pamphlets without any active intervention by the study team.
Receives: Other: Routine care arm

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of m-LIfE application (Recruitment Rate)

    Recruitment rate will be measured as the percentage of participants enrolled out of the total number of eligible participants invited to receive m-LIfE intervention. The trial will be considered feasible if recruitment rate exceeds 70%.

    Units of Measure: Percentage (%)

    Measured: Recruitment rate will be measured at baseline.

  2. Feasibility of m-LIfE application (Retention Rate)

    Retention rate will be measured as the percentage of participants who complete the post-intervention assessment at 12 weeks, out of those who were initially enrolled. The intervention will be considered feasible if the retention rate exceeds 70%.

    Units of Measure: Percentage (%)

    Measured: Retention rate will be measured at post-intervention (Week 12, immediately after the intervention ends)

  3. Feasibility of m-LIfE application (Treatment Fidelity)

    The treatment fidelity rate will be measured as the percentage of planned health-promoting sessions successfully delivered during the 12-week intervention period.

    The intervention will be considered feasible if the treatment fidelity rate exceeds 70%.

    Units of Measure: Percentage (%)

    Measured: Treatment fidelity will be measured at post-intervention (Week 12, immediately after the intervention ends)

Secondary outcomes (1)
  1. Potential efficacy of m-LIfE application (Physical activity)

    The duration of physical activity will be measured as the mean change in the daily step count.

    Unit of Measure: Step count

    Measured: Data will be collected at three time points: baseline (Week 0), post-intervention (Week 12), and follow-up (Week 16, four weeks after the intervention ends).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2025
  2. Study start22 Jun 2026
  3. Primary completionOct 2026 (estimated)
  4. Study completionNov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
84 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06981247
Sponsor's protocol ID
ERC No. 2025-9680-29143
Acronym
m-LIfE
Status last verified
Aug 2026
First submitted
19 Apr 2025
Last updated
12 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: We plan to share deidentified IPD with other researchers. The shared data will include deidentified participant behavioral risk factors, and other relevant variables collected during the study. Access to the data will be granted upon reasonable request. A data-sharing agreement that outlines the intended use of the data will be signed. Researchers requesting the data will need to adhere to ethical guidelines and data protection policies.

Publications

  • Elahi A, Ali AA, Khan AH, Samad Z, Shahab H, Aziz N, Almas A. Challenges of managing hypertension in Pakistan - a review. Clin Hypertens. 2023 Jun 15;29(1):17. doi: 10.1186/s40885-023-00245-6.

    PubMed 37316940
  • Akhtar S, Samad Z, Bloomfield GS, Ajani K, Virani SS, Awan S, Almas A. m-Lifestyle Intervention for Employees (m-LIfE): protocol for a pilot cluster randomized controlled trial on cardiovascular disease prevention strategies. Pilot Feasibility Stud. 2026 Apr 7;12(1):82. doi: 10.1186/s40814-026-01815-9.

    PubMed 41947180

Questions about this trial

What is this clinical trial studying?

A study testing m-LIfE: mobile based lifestyle intervention for employees to increase their physical activity and promote healthy diet. and Routine care arm in people with Physical Activity and Life Style, run by Aga Khan University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Samina Akhtar (+923314312920, samina.yousanaf@aku.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of m-LIfE application (Recruitment Rate) (time frame: Recruitment rate will be measured at baseline.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06981247, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in